Market expansion is supported by increasing R&D in cell and gene therapies, especially CRISPR and stem cell techniques. The rise in prenatal and copyright screening, particularly across Asia and the Middle East, is contributing significantly to market demand and early diagnosis rates. https://www.datamintelligence.com/research-report/alpha-thalassemia-market